Home/Filings/4/0001181431-09-004241
4//SEC Filing

OXIGENE INC 4

Accession 0001181431-09-004241

$OTLCCIK 0000908259operating

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 11:47 AM ET

Size

5.4 KB

Accession

0001181431-09-004241

Insider Transaction Report

Form 4
Period: 2009-01-20
CHAPLIN DAVID
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2009-01-20+120,000120,000 total
    Exercise: $0.65From: 2010-01-20Exp: 2019-01-20Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]The option vests in four equal annual installments starting one year from the date of grant.

Issuer

OXIGENE INC

CIK 0000908259

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000908259

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 11:47 AM ET
Size
5.4 KB